Ethionamide (CAS 536-33-4)

Ethionamide, identified by the CAS number 536-33-4, is a synthetic compound structurally related to thioamide. Its primary mechanism of action lies in its ability to inhibit mycolic acid synthesis, a crucial component of the cell wall of mycobacteria. Ethionamide is activated within bacterial cells by a specific enzyme, EthA, into an active form that targets InhA, an enoyl-ACP reductase involved in fatty acid synthesis. By inhibiting InhA, ethionamide interferes with the production of mycolic acids, thereby disrupting the bacterial cell wall synthesis and compromising the integrity and viability of the bacterial cell. In research settings, ethionamide has been extensively used to study the biochemical pathways of mycobacterial resistance and the pharmacological modulation of antimycobacterial activity. This research has been instrumental in understanding how modifications within the structural design of thioamide derivatives can influence their efficacy against mycobacteria. Additionally, studies involving ethionamide have contributed to the broader field of tuberculosis research by elucidating the genetic mechanisms that mycobacteria employ to develop resistance against antimycobacterial compounds. This has significant implications for the development of new strategies and compounds to combat mycobacterial infections, particularly in strains resistant to conventional treatments.